v3.25.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
CASH USED IN OPERATING ACTIVITIES        
Net income (loss) $ 754 $ (10,909) $ 5,420 $ (3,846)
Adjustments to reconcile net income (loss) to cash used in operating activities:        
Share-based compensation     542 1,330
Amortization of intangible assets 269 269 807 807
Depreciation 503 499 1,505 1,057
Excess of fair value of warrants over proceeds of private placement     0 659
Change in fair value of warrant liabilities (3,768) 7,576 (17,939) (7,945)
Loss on warrants modification 0 0 2,444 0
Changes in assets and liabilities:        
Accounts receivable     (90) (833)
Inventory     0 (1,070)
Prepaid expenses     (31) 86
Lease liability     2 0
Trade payables and other liabilities     (578) (1,315)
Net cash used in operating activities     (7,918) (11,070)
CASH USED IN INVESTING ACTIVITIES        
Purchase of equipment     (367) (1,182)
Net cash used in investing activities     (367) (1,182)
CASH PROVIDED BY FINANCING ACTIVITIES        
Proceeds from private placement of shares and warrants     7,000 16,867
Share issuance costs     (323) (206)
Net cash provided by financing activities     6,677 16,661
Net change in cash     (1,608) 4,409
Beginning cash balance     10,737 1,026
Ending cash balance $ 9,129 $ 5,435 9,129 5,435
Supplemental disclosures of non-cash transactions:        
Share issuance costs included in trade payables and other liabilities     20 0
Shares issued for debt settlement     679 0
Value of common shares issued share issuance costs     0 1,005
Private placement proceeds allocated to warrant liability     6,428 15,442
Accounts receivable settled through share cancellation     $ 75 $ 0